PRETARG-IT
LIVE

Serial Number

79345233

Owner

OncoOne Research & Development GmbH

Filing Date

May 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PRETARG-IT Trademark

Serial Number: 79345233 • Registration: 7095573

PRETARG-IT is a trademark filed by OncoOne Research & Development GmbH on May 25, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

OncoOne Research & Development GmbH (5 trademarks)

Höhenstraße 19/2

Entity Type: 99

Trademark Details

Filing Date

May 25, 2022

Registration Date

July 4, 2023

Published for Opposition

April 18, 2023

Goods & Services

Pharmaceuticals and veterinary preparations, namely, pharmaceutical preparations comprising antibodies for the treatment and prevention of diseases, namely, hyperproliferative and inflammatory diseases; pharmaceuticals and veterinary preparations, namely, pharmaceutical preparations comprising antigen binding fragments for the treatment and prevention of diseases, namely, hyperproliferative and inflammatory diseases; preparations for medical and veterinary purposes comprising antibodies for the treatment and prevention of diseases, namely, hyperproliferative and inflammatory diseases; preparations for medical and veterinary purposes comprising antigen binding fragments for the treatment and prevention of diseases, namely, hyperproliferative and inflammatory diseases

Scientific and technological services, namely, scientific research in the field of diseases using antibodies; scientific and technological services, namely, scientific research in the field of diseases using antibodies and antigen binding fragments thereof; industrial analysis and research services in the field of diseases using antibodies; industrial analysis and research services in the field of diseases using antigen binding fragments thereof, and medical research services; pharmaceutical and biotechnological research and development; biotechnological research services

Medical and veterinary services, namely, services for the treatment and prevention of diseases using antibodies; medical and veterinary services, namely, services for the treatment and prevention of diseases using antigen binding fragments thereof

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
NOTIFICATION PROCESSED BY IB
Aug 27, 2023 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 10, 2023 FICS
FINAL DISPOSITION PROCESSED
Aug 10, 2023 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 3, 2023 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 4, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Apr 25, 2023 GPNX
PUBLISHED FOR OPPOSITION
Apr 18, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 5, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 5, 2023 OP2R
NOTICE OF PUBLICATION
Mar 29, 2023 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2023 CNSA
ASSIGNED TO EXAMINER
Mar 14, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 19, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 14, 2022 REPR